Literature DB >> 15943822

Clinical relevance of macroprolactin.

James Gibney1, Thomas P Smith, T Joseph McKenna.   

Abstract

Mesh:

Substances:

Year:  2005        PMID: 15943822     DOI: 10.1111/j.1365-2265.2005.02243.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


× No keyword cloud information.
  12 in total

1.  Prevalence of pituitary adenomas in macroprolactinemic patients may be higher than it is presumed.

Authors:  Gonca Tamer; Ayşegül Telci; Meral Mert; Ayse Kubat Uzum; Ferihan Aral; Refik Tanakol; Sema Yarman; Harika Boztepe; Nese Colak; Faruk Alagöl
Journal:  Endocrine       Date:  2011-09-30       Impact factor: 3.633

2.  Prevalence and reproductive manifestations of macroprolactinemia.

Authors:  Amanpreet Kaur Kalsi; Ashutosh Halder; Manish Jain; P K Chaturvedi; J B Sharma
Journal:  Endocrine       Date:  2018-09-29       Impact factor: 3.633

3.  Macroprolactinemia, like hyperprolactinemia, may promote platelet activation.

Authors:  Inan Anaforoglu; Melek Eda Ertorer; Ilknur Kozanoglu; Birsel Unal; Filiz Eksi Haydardedeoglu; Okan Bakiner; Emre Bozkirli; Neslihan Bascil Tutuncu; Nilgun Guvener Demirag
Journal:  Endocrine       Date:  2010-02-03       Impact factor: 3.633

Review 4.  Prolactin Biology and Laboratory Measurement: An Update on Physiology and Current Analytical Issues.

Authors:  Mohamed Saleem; Helen Martin; Penelope Coates
Journal:  Clin Biochem Rev       Date:  2018-02

5.  Serum prolactin and macroprolactin levels among outpatients with major depressive disorder following the administration of selective serotonin-reuptake inhibitors: a cross-sectional pilot study.

Authors:  Sollip Kim; Young-Min Park
Journal:  PLoS One       Date:  2013-12-02       Impact factor: 3.240

6.  Sexual function and depressive symptoms in young women with elevated macroprolactin content: a pilot study.

Authors:  Robert Krysiak; Agnieszka Drosdzol-Cop; Violetta Skrzypulec-Plinta; Bogusław Okopien
Journal:  Endocrine       Date:  2016-02-22       Impact factor: 3.633

7.  Hyperprolactinaemia - a problem in patients from the reproductive period to the menopause.

Authors:  Sylwia Pałubska; Aneta Adamiak-Godlewska; Izabela Winkler; Katarzyna Romanek-Piva; Tomasz Rechberger; Marek Gogacz
Journal:  Prz Menopauzalny       Date:  2017-04-26

8.  Prevalence of macroprolactinaemia in regularly menstruating women with non-toxic goitre or autoimmune thyroid disease.

Authors:  Krzysztof C Lewandowski; Danuta Gąsior-Perczak; Aldona Kowalska; Andrzej Lewiński
Journal:  Thyroid Res       Date:  2012-12-17

Review 9.  Macroprolactinemia: diagnostic, clinical, and pathogenic significance.

Authors:  Akira Shimatsu; Naoki Hattori
Journal:  Clin Dev Immunol       Date:  2012-12-04

Review 10.  Macroprolactinemia: new insights in hyperprolactinemia.

Authors:  Miro Kasum; Slavko Oreskovic; Ivana Zec; Davor Jezek; Vlatka Tomic; Vesna Gall; Goran Adzic
Journal:  Biochem Med (Zagreb)       Date:  2012       Impact factor: 2.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.